Non-publication of clinical trial results has been recognized as a serious scientific and ethical problem. Underreporting frustrates evaluation of a drug’s utility and safety, and fails to redeem the sacrifice of trial participants. Thus far, policy measures to counteract non-publication have focused on trials of interventions used in practice. However, 9/10 interventions entering clinical testing… Continue reading Accessibility of trial reports for drugs stalling in development: a systematic assessment of registered trials
Studies of Translation in Ethics and Medicine